← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alphathera, Inc.
Bryn Mawr, PA
$4,589,674
Total funding
5
Grants
Funding over time
peak $1.1M · FY2017–22$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,589,674 · 5
By mechanism
R44$3,869,242 · 2
R41$449,552 · 2
R43$270,880 · 1
Investigators at Alphathera, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Generation of antibody-drug conjugates by proximity-based sortase-mediated ligation$1,081,188
R44 · FY2021 · CA
Tools for the site-specific labeling and immobilization of antibodies for immunoassays$764,390
R44 · FY2018 · EB
Tools for the site-specific labeling and immobilization of antibodies for immunoassays$695,910
R44 · FY2019 · EB
Generation of antibody-drug conjugates by proximity-based sortase-mediated ligation$610,986
R44 · FY2022 · CA
An ELISA and homogeneous assay for serological diagnosis of SARS-CoV2 antibodies$547,186
R44 · FY2020 · EB
TRIM21-mediated degradation of antibody-targeted cytosolic proteins$270,880
R43 · FY2020 · CA
Preparation of site-specific antibody-drug conjugates by proximity-based sortase ligation$224,996
R41 · FY2017 · CA
Tools for site-specific antibody immobilization for immunoassays$224,556
R41 · FY2017 · EB
An ELISA and homogeneous assay for serological diagnosis of SARS-CoV2 antibodies$119,588
R44 · FY2020 · EB
TABA: Tools for the site-specific labeling and immobilization of antibodies for immunoassays$49,994
R44 · FY2021 · EB